Breaking News Instant updates and real-time market news.

NSRGY

Nestle

$0.00

(0.00%)

, UN

Unilever; also tag UL

$55.84

0.33 (0.59%)

04:51
10/02/18
10/02
04:51
10/02/18
04:51

Nestle upgraded to Buy from Hold at Jefferies

Jefferies analyst Martin Deboo upgraded Nestle (NSRGY) to Buy saying he's more bullish on the new CEO and the shares into the second half of the year. The analyst switched his top pick in the food and home and personal care sector to Nestle from Unilever (UN) on better upside potential. He downgraded Unilever this morning to Hold.

NSRGY

Nestle

$0.00

(0.00%)

UN

Unilever; also tag UL

$55.84

0.33 (0.59%)

UL

Unilever; also tag UN

$55.24

0.27 (0.49%)

  • 03

    Mar

NSRGY Nestle
$0.00

(0.00%)

05/16/18
SPHN
05/16/18
INITIATION
Target $16
SPHN
Overweight
Codexis initiated with an Overweight at Stephens
Stephens analyst Drew Jones started Codexis (CDXS) with an Overweight rating and $16 price target, stating that the company's CodeEvolver platform technology has been sought by pharma partners Merck (MRK), GlaxoSmithKline (GSK) and Nestle (NSRGY) and he expects continued deeper adoption from other major industry players.
06/26/18
JEFF
06/26/18
NO CHANGE
Target $61
JEFF
Buy
Starbucks price target cut to $61 from $69 at Jefferies, says stock 'bottoming'
Jefferies analyst Andy Barish cut his price target on Starbucks (SBUX) to $61 from $69 following last week's guidance cut and May's strategic alliance with Nestle (NSRGY). Barish tells investors in a research note that "clearly a transition is taking place," with Starbucks moving from visible growth to a choppier growth company. Barish, who believes the stock is bottoming and valuation supports his Buy rating, reduced his FY18/FY19 EPS view to $2.75/$2.40 from $2.75/$2.59 based on updated guidance on softer same-store sales in the Americas and China and deleverage. While the China growth story remains, Barish believes the SSS shortfall could persist "for some time" until Starbucks resolves internal Mobile Order and Pay and partners on delivery.
08/31/18
TIGR
08/31/18
NO CHANGE
TIGR
Neutral
Tigress reiterates Neutral on Coca-Cola after 'bold' Costa acquisition
Tigress Financial analyst Ivan Feinseth reiterates a Neutral rating on Coca-Cola (KO) shares following the company's acquisition of Costa. The deak positions Coca-Cola "in the center of the very competitive coffee-based beverage business" where it will compete head-on with Starbucks (SBUX) and Nestle (NSRGY), Feinseth tells investors in a research note. The Costa acquisition is a "bold move" by Coca-Cola as it continues trying to expand outside of its core beverage business and increase its retail presence, the analyst adds. He believes, however, that "intense" competition in the beverage industry, coupled with ongoing changes in consumer tastes, creates "significant Business Performance headwinds" for Coke.
09/04/18
EXAN
09/04/18
UPGRADE
EXAN
Neutral
Nestle upgraded to Neutral from Underperform at Exane BNP Paribas
UN Unilever; also tag UL
$55.84

0.33 (0.59%)

03/28/18
UBSW
03/28/18
UPGRADE
UBSW
Buy
UBS sees 'compelling' entry point for Unilever, upgrades to Buy
UBS analyst Pinar Ergun upgraded Unilever to Buy saying the 17% pullback in the shares since the October 2017 peak has created a "compelling" entry point. The analyst sees no reason to lower 2018 estimates and expects gradually improving volume growth and ongoing EBIT margin expansion. Ergun keeps a EUR 49 price target for the shares.
03/28/18
03/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) and AT&T (T) were upgraded to Buy from Hold at HSBC. 2. Unilever (UN, UL) upgraded to Buy from Neutral at UBS with analyst Pinar Ergun saying the 17% pullback in the shares since the October 2017 peak has created a "compelling" entry point. 3. Rockwell Automation (ROK) upgraded to Outperform from Market Perform at Wells Fargo with analyst Richard Kwas saying the company's fiscal 2018 organic growth "has room to outperform" while its fiscal 2017 restructuring should yield "steady margin benefits" into fiscal 2019. 4. Jacobs Engineering (JEC) upgraded to Buy from Neutral at MKM Partners with analyst Daniel Scott saying he is positive on the combination with CH2M and expects the company to benefit from increased spending on defense and infrastructure. 5. Burberry (BURBY) upgraded to Buy from Neutral at Goldman Sachs with analyst Louise Singlehurst citing increased confidence in the medium-term outlook for European luxury growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/21/18
ARGS
08/21/18
NO CHANGE
Target $65
ARGS
Buy
Unilever price target raised to $65 from $60 at Argus
Argus analyst Jim Kelleher raised his price target on Unilever (UN, UL) to $65 and kept his Buy rating, saying that the company has made progress in its organization structure and "niche" M&A selections ever since rebuffing the Kraft Heinz (KHC) takeover offer. The analyst further cites the company's margin expansion and defensive steps such as becoming incorporated in the Netherlands, where it is harder for major companies to launch hostile bids. Kelleher expects Unilever to grow its earnings faster than the industry average as its management reaches its operating margin targets, adding that the company's dividend yield is also "attractive in a low-rate environment".
10/02/18
JEFF
10/02/18
DOWNGRADE
JEFF
Hold
Unilever downgraded to Hold from Buy at Jefferies
Jefferies analyst Martin Deboo downgraded Unilever to Hold saying the company is facing "choppier waters" and "higher expectations." The analyst sees near-term risk from Unilever's planned single listing as well as its exposure to Argentina and Turkey.
UL Unilever; also tag UN
$55.24

0.27 (0.49%)

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$77.62

(0.00%)

09:43
10/23/18
10/23
09:43
10/23/18
09:43
Recommendations
VF Corp. analyst commentary  »

VF Corp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$95.61

(0.00%)

09:42
10/23/18
10/23
09:42
10/23/18
09:42
Technical Analysis
Technical Take: Market Vectors Semiconductor at new 52-week low, major top »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$204.52

(0.00%)

09:40
10/23/18
10/23
09:40
10/23/18
09:40
Options
Unusually active option classes on open October 23rd »

Unusual total active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HON

Honeywell

$152.63

-0.86 (-0.56%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
Honeywell rating change  »

Honeywell upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

$40.40

-0.59 (-1.44%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
QTS Realty Trust rating change  »

QTS Realty Trust upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$261.03

0.97 (0.37%)

09:38
10/23/18
10/23
09:38
10/23/18
09:38
Periodicals
Breaking Periodicals news story on Tesla »

Citron says long Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

KOF

Coca-Cola Femsa

$59.41

-1.75 (-2.86%)

09:36
10/23/18
10/23
09:36
10/23/18
09:36
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.93

0.34 (0.71%)

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Oracle initiated  »

Oracle initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Conference/Events
JPMorgan European & EMEA analysts to hold analyst/industry conference call »

European Utilities…

ABBV

AbbVie

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
AbbVie initiated  »

AbbVie initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SNY

Sanofi

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Sanofi initiated  »

Sanofi reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

RHHBY

Roche

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Roche initiated  »

Roche reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 24

    Dec

09:35
10/23/18
10/23
09:35
10/23/18
09:35
General news
Treasury 2-year auction outlook: the $38 B 2-year sale »

Treasury 2-year auction…

PFE

Pfizer

$44.37

-0.13 (-0.29%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Pfizer initiated  »

Pfizer reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

GSK

GlaxoSmithKline

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
GlaxoSmithKline initiated  »

GlaxoSmithKline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 07

    Nov

LLY

Eli Lilly

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Eli Lilly initiated  »

Eli Lilly reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

NVS

Novartis

$87.12

-0.07 (-0.08%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Novartis initiated  »

Novartis reinitiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MRK

Merck

$72.56

0.22 (0.30%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Merck initiated  »

Merck reinitiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

BMY

Bristol-Myers

$50.87

-3.44 (-6.33%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Bristol-Myers initiated  »

Bristol-Myers reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 20

    May

AZN

AstraZeneca

$39.50

0.295 (0.75%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
AstraZeneca initiated  »

AstraZeneca reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

MLCO

Melco Resorts & Entertainment

$17.74

-0.04 (-0.22%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Downgrade
Melco Resorts & Entertainment rating change  »

Melco Resorts &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.10

-0.56 (-2.10%)

, BAC

Bank of America

$27.36

-0.95 (-3.36%)

09:33
10/23/18
10/23
09:33
10/23/18
09:33
Technical Analysis
Technical Take: Bank of America drops in early trading »

The shares were last down…

XLF

Financial Select Sector

$26.10

-0.56 (-2.10%)

BAC

Bank of America

$27.36

-0.95 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

UTX

United Technologies

$126.42

-2.22 (-1.73%)

09:33
10/23/18
10/23
09:33
10/23/18
09:33
Hot Stocks
United Technologies says geo-political outlook is the biggest concern »

Says tariffs present a 5c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UBS

UBS

$13.77

-0.085 (-0.61%)

09:32
10/23/18
10/23
09:32
10/23/18
09:32
Periodicals
UBS backs down warning to staff about traveling to China, FT reports »

UBS has rescinded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.